Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Breast Cancer |
Free Subscription
10 Ann Surg Oncol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Breast Cancer is free of charge.
ASO Visual Abstract: A Prospective Study of Sentinel Node Biopsy Omission
in Women Age >/= 65 with ER+ Breast Cancer.
Ann Surg Oncol. 2024 Mar 6. doi: 10.1245/s10434-024-15137.
PubMed
Clinical Outcomes of Transaxillary Reverse-Sequence Endoscopic Nipple-Sparing
Mastectomy and Direct-to-Implant Prepectoral Breast Reconstruction: A Prospective
Study of Initial 68 Procedures.
Ann Surg Oncol. 2024;31:2777-2785.
PubMed
Abstract available
ASO Author Reflections: What Can Prediction Models for Upstaging of DCIS
Diagnosed on Biopsy Tell Us About DCIS Surveillance Trials?
Ann Surg Oncol. 2024;31:2272-2273.
PubMed
ASO Visual Abstract: Lobular Neoplasia Diagnosed by MRI-Guided Breast
Biopsy-Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and
Surgical Management.
Ann Surg Oncol. 2024;31:2276-2277.
PubMed
Society of Surgical Oncology Breast Disease Site Working Group Statement on
Contralateral Mastectomy: Indications, Outcomes, and Risks.
Ann Surg Oncol. 2024;31:2212-2223.
PubMed
Abstract available
Early Complications in Prepectoral Tissue Expander-Based Breast Reconstruction.
Ann Surg Oncol. 2024;31:2766-2776.
PubMed
Abstract available
ASO Author Reflections: A Novel Technique of Transaxillary Reverse-Sequence
Endoscopic Nipple-Sparing Mastectomy and Direct-to-Implant Prepectoral Breast
Reconstruction.
Ann Surg Oncol. 2024;31:2791-2792.
PubMed
Do HER2-Low Tumors Have a Distinct Clinicopathologic Phenotype?
Ann Surg Oncol. 2024;31:2231-2243.
PubMed
Abstract available
ASO Visual Abstract: Clinical Outcomes of Transaxillary Reverse-Sequence
Endoscopic Nipple-Sparing Mastectomy and Direct-to-Implant Prepectoral Breast
Reconstruction-A Prospective Study of Initial 68 Procedures.
Ann Surg Oncol. 2024;31:2794-2795.
PubMed
Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy: Identifying Upgrade Rate
to Malignancy and Outcomes of Clinical and Surgical Management.
Ann Surg Oncol. 2024;31:2224-2230.
PubMed
Abstract available
Epidemiological, clinical, and pathological characteristics of invasive breast
cancer in Bedouin and Jewish women in southern Israel: a retrospective
comparative study.
BMC Cancer. 2024;24:310.
PubMed
Abstract available
Rural-urban disparity in cancer burden and care: findings from an Indian cancer
registry.
BMC Cancer. 2024;24:308.
PubMed
Abstract available
Economic evaluation of germline genetic testing for breast cancer in low- and
middle-income countries: a systematic review.
BMC Cancer. 2024;24:316.
PubMed
Abstract available
Exploration of the relationship between tumor-infiltrating lymphocyte score and
histological grade in breast cancer.
BMC Cancer. 2024;24:318.
PubMed
Abstract available
MMP-11 expression in early luminal breast cancer: associations with clinical,
MRI, pathological characteristics, and disease-free survival.
BMC Cancer. 2024;24:295.
PubMed
Abstract available
A cost-benefit analysis of genetic screening test for breast cancer in Iran.
BMC Cancer. 2024;24:279.
PubMed
Abstract available
The novel circRNA circ_0045881 inhibits cell proliferation and invasion by
targeting mir-214-3p in triple-negative breast cancer.
BMC Cancer. 2024;24:278.
PubMed
Abstract available
Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced
or metastatic breast cancer: recommendations from the Japanese Breast Cancer
Society Clinical Practice Guidelines.
Breast Cancer. 2024 Mar 4. doi: 10.1007/s12282-024-01550.
PubMed
Abstract available
Deep learning model to predict Ki-67 expression of breast cancer using digital
breast tomosynthesis.
Breast Cancer. 2024 Mar 7. doi: 10.1007/s12282-024-01549.
PubMed
Abstract available
A prospective comparison study utilizing patient-reported outcomes of
taxane-related peripheral neuropathy between nab-paclitaxel and standard
paclitaxel in patients with breast cancer.
Breast Cancer. 2024 Mar 8. doi: 10.1007/s12282-024-01551.
PubMed
Abstract available
Breast Cancer (Dove Med Press)
Antibody-Drug Conjugates in Breast Cancer: A Comprehensive Review of How to
Selectively Deliver Payloads.
Breast Cancer (Dove Med Press). 2024;16:51-70.
PubMed
Abstract available
Clinically relevant gene signatures provide independent prognostic information in
older breast cancer patients.
Breast Cancer Res. 2024;26:38.
PubMed
Abstract available
How does weight gain since the age of 18 years affect breast cancer risk in later
life? A meta-analysis.
Breast Cancer Res. 2024;26:39.
PubMed
Abstract available
A risk analysis of alpelisib-induced hyperglycemia in patients with advanced
solid tumors and breast cancer.
Breast Cancer Res. 2024;26:36.
PubMed
Abstract available
Overcoming doxorubicin resistance in triple-negative breast cancer using the
class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis.
Breast Cancer Res. 2024;26:35.
PubMed
Abstract available
Burden of female breast cancer in India: estimates of YLDs, YLLs, and DALYs at
national and subnational levels based on the national cancer registry programme.
Breast Cancer Res Treat. 2024 Mar 4. doi: 10.1007/s10549-024-07264.
PubMed
Abstract available
Survival among patients with untreated metastatic breast cancer: "What if I do
nothing?".
Breast Cancer Res Treat. 2024 Mar 5. doi: 10.1007/s10549-024-07265.
PubMed
Abstract available
Immunohistochemical assessment of HER2 low breast cancer: interobserver
reproducibility and correlation with digital image analysis.
Breast Cancer Res Treat. 2024 Mar 5. doi: 10.1007/s10549-024-07256.
PubMed
Abstract available
A whole-food, plant-based randomized controlled trial in metastatic breast
cancer: weight, cardiometabolic, and hormonal outcomes.
Breast Cancer Res Treat. 2024 Mar 6. doi: 10.1007/s10549-024-07266.
PubMed
Abstract available
Intertumoral heterogeneity of bifocal breast cancer: a morphological and
molecular study.
Breast Cancer Res Treat. 2024 Mar 7. doi: 10.1007/s10549-024-07281.
PubMed
Abstract available
Identify risk factors affecting participation of Turkish women in mammography
screening for breast cancer prevention.
Breast Cancer Res Treat. 2024 Mar 7. doi: 10.1007/s10549-024-07296.
PubMed
Abstract available
Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack
of prognostic utility and biological correlates across tumor subtypes.
Breast Cancer Res Treat. 2024 Mar 7. doi: 10.1007/s10549-024-07286.
PubMed
Abstract available
Survival analysis of patients with brain metastases at initial breast cancer
diagnosis over the last decade.
Breast Cancer Res Treat. 2024 Mar 7. doi: 10.1007/s10549-024-07290.
PubMed
Abstract available
Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and
pathological complete response in patients with HER2-positive early breast cancer
treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab.
Breast Cancer Res Treat. 2024 Mar 8. doi: 10.1007/s10549-024-07292.
PubMed
Abstract available
Selective Capsulotomies and Partial Capsulectomy in Implant-Based Breast
Reconstruction Revision Surgery.
Breast J. 2024;2024:9097040.
PubMed
Abstract available
Nonclinical factors associated with the treatment of older women with newly
diagnosed low-grade ductal carcinoma in situ.
Cancer. 2024;130:1041-1051.
PubMed
Abstract available
Cardiotoxicity of breast cancer drugs requires additional monitoring.
Cancer. 2024;130:1013-1014.
PubMed
Routine estradiol testing recommended for women at high risk of breast cancer.
Cancer. 2024;130:1014.
PubMed
Visceral obesity and sarcopenia as predictors of efficacy and hematological
toxicity in patients with metastatic breast cancer treated with CDK 4/6
inhibitors.
Cancer Chemother Pharmacol. 2024 Mar 4. doi: 10.1007/s00280-024-04641.
PubMed
Abstract available
Vitamin D suppresses CD133+/CD44 + cancer stem cell stemness by inhibiting NF-kappaB
signaling and reducing NLRP3 expression in triple-negative breast cancer.
Cancer Chemother Pharmacol. 2024 Mar 8. doi: 10.1007/s00280-024-04660.
PubMed
Abstract available
Cancer Epidemiol Biomarkers Prev
Physical Activity and Mammographic Density in Japanese Women.
Cancer Epidemiol Biomarkers Prev. 2024;33:365-370.
PubMed
Abstract available
A Novel Approach for Conducting a Catchment Area Analysis of Breast Cancer by Age
and Stage for a Community Cancer Center.
Cancer Epidemiol Biomarkers Prev. 2024 Mar 7. doi: 10.1158/1055-9965.EPI-23-1125
PubMed
Abstract available
K48-linked deubiquitination of VGLL4 by USP15 enhances the efficacy of tumor
immunotherapy in triple-negative breast cancer.
Cancer Lett. 2024 Feb 29:216764. doi: 10.1016/j.canlet.2024.216764.
PubMed
Abstract available
CYR61 confers chemoresistance by upregulating survivin expression in
triple-negative breast cancer.
Carcinogenesis. 2024 Mar 6:bgae013. doi: 10.1093.
PubMed
Abstract available
BCAR4 Expression as a Predictive Biomarker for Endocrine Therapy Resistance in
Breast Cancer.
Clin Breast Cancer. 2024 Feb 16:S1526-8209(24)00047.
PubMed
Abstract available
New Strategies for Locally Advanced Breast Cancer: A Review of Inflammatory
Breast Cancer and Nonresponders.
Clin Breast Cancer. 2024 Jan 21:S1526-8209(24)00009.
PubMed
Abstract available
Association Between Multiple Single Nucleotide Polymorphisms in Folate Metabolism
Pathway and Breast Cancer Risk in Georgian Women: A Case-Control Study.
Clin Med Insights Oncol. 2024;18:11795549241233693.
PubMed
Abstract available
The prevalence of ADSL (rs3788579) and CYP1A2 (rs17861162) polymorphisms in
female breast cancer patients in North-West Iran.
Discov Oncol. 2024;15:59.
PubMed
Abstract available
Training pathologists to assess stromal tumour-infiltrating lymphocytes in breast
cancer synergises efforts in clinical care and scientific research.
Histopathology. 2024 Mar 3. doi: 10.1111/his.15140.
PubMed
Abstract available
Neutrophil-lymphocyte ratio reflects tumour-infiltrating lymphocytes and
tumour-associated macrophages and independently predicts poor outcome in breast
cancers with neoadjuvant chemotherapy.
Histopathology. 2024;84:810-821.
PubMed
Abstract available
Tumour 63 protein (p63) in breast pathology: biology, immunohistochemistry,
diagnostic applications, and pitfalls.
Histopathology. 2024;84:723-741.
PubMed
Abstract available
Unraveling the cross-talk between N6-methyladenosine modification and non-coding
RNAs in breast cancer: Mechanisms and clinical implications.
Int J Cancer. 2024 Mar 1. doi: 10.1002/ijc.34900.
PubMed
Abstract available
Efficacy and safety of everolimus plus exemestane in patients with hormone
receptor-positive, HER-2-negative advanced breast cancer: Results from the
open-label, multicentre, non-interventional BRAWO study.
Int J Cancer. 2024 Mar 6. doi: 10.1002/ijc.34912.
PubMed
Abstract available
Revolutionizing breast cancer treatment: Harnessing the related mechanisms and
drugs for regulated cell death (Review).
Int J Oncol. 2024;64:46.
PubMed
Abstract available
Out-of-pocket cost modeling of adjuvant antiestrogen and radiation therapy after
lumpectomy for early-stage breast cancer across Medicaid and Medicare plans.
Int J Radiat Oncol Biol Phys. 2024 Mar 1:S0360-3016(24)00351.
PubMed
Abstract available
Beyond survival: a closer look at lead-time bias and disease-free intervals in
mammography screening.
J Natl Cancer Inst. 2024;116:343-344.
PubMed
The unique risk factor profile of triple negative breast cancer: a comprehensive
meta-analysis.
J Natl Cancer Inst. 2024 Mar 5:djae056. doi: 10.1093.
PubMed
Abstract available
Detailed DNA methylation characterisation of phyllodes tumours identifies a
signature of malignancy and distinguishes phyllodes from metaplastic breast
carcinoma.
J Pathol. 2024;262:480-494.
PubMed
Abstract available
Forget lung, breast or prostate cancer? Why we shouldn't abandon tumour names
yet.
Nature. 2024;627:38.
PubMed
Cell-cycle inhibition and immune microenvironment in breast cancer treated with
ribociclib and letrozole or chemotherapy.
NPJ Breast Cancer. 2024;10:20.
PubMed
Abstract available
Awareness regarding breast cancer amongst women in Pakistan: A systematic review
and meta-analysis.
PLoS One. 2024;19:e0298275.
PubMed
Abstract available
Aspects to consider regarding breast cancer risk in trans men: A systematic
review and risk management approach.
PLoS One. 2024;19:e0299333.
PubMed
Abstract available
Protocol to measure validity and reliability of colorectal, breast, cervical and
lung cancer screening questions from the 2021 National Health Interview Survey:
Methodology and design.
PLoS One. 2024;19:e0297773.
PubMed
Abstract available
Telling time in tumor samples reveals diversity of clock disruption.
Proc Natl Acad Sci U S A. 2024;121:e2401496121.
PubMed
Fatigue and vigilance in medical experts detecting breast cancer.
Proc Natl Acad Sci U S A. 2024;121:e2309576121.
PubMed
Abstract available
Corrigendum to "Safety and feasibility of CDK4/6 inhibitors treatment combined
with radiotherapy in patients with HR-positive/HER2-negative breast cancer. A
systematic review and meta-analysis" [Radiother. Oncol. 187 (2023) 109839].
Radiother Oncol. 2024;194:110188.
PubMed
Benefit of respiratory gating in the Danish Breast Cancer Group partial breast
irradiation trial.
Radiother Oncol. 2024 Mar 3:110195. doi: 10.1016/j.radonc.2024.110195.
PubMed
Abstract available
Long-term results of intraoperative multicatheter breast implant (IOMBI) for
accelerated partial breast irradiation (APBI) on early breast cancer patients.
Radiother Oncol. 2024;194:110193.
PubMed
Abstract available
Thank you for your interest in scientific medicine.